Date: Wednesday, December 16, 2020
<Back to Mini Symposia Main Page
2020 Program Chair: Sebastian Bonnet, PhD, FAHA
2021 Program Chair: Elena A. Goncharova, PhD
2021 Chair-Elect: Brian B. Graham, MD
Moderated By: Andrea Frump, MS, PhD, Werner Seeger, MD and Soban Umar, MD, PhD
-
SGLT2 Inhibition Ameliorates Exercise-Induced Pulmonary Hypertension (EIPH) in Heart Failure with Preserved Ejection Fraction – Taijyu Satoh, MD, PhD (2:37)
-
Role of PKM2-PARP1/Inflammation/Oxidative DNA Damage Axis in the Pathogenesis of Right Ventricular Failure Associated with Pulmonary Arterial Hypertension – Tsukasa Shimauchi, MD, PhD (12:52)
-
Loss of Estrogen Receptor Alpha (ERα) Worsens Hemodynamic Alterations and Right Ventricular (RV) Adaptation in Female Rats with Pulmonary Hypertension (PH) – Andrea Frump, PhD (25:08)
-
Long Non-Coding RNA H19 Promotes Right Ventricular Failure in PAH – Junichi Omura, MD, PhD (37:04)
-
Litaf-Dependent Pericyte Signaling Perpetuates Vascular Inflammation in Pulmonary Hypertension – David Condon, MD (48:11)
-
Mutation of the Epigenetic Regulatortet2 Is Associated with Increased Inflammation in Pulmonary Arterial Hypertension – Francois Potus, PhD (1:01:00)
-
Y-Chromosome Gene, Uty, Protects Against Pulmonary Hypertension by Reducing Proinflammatory Cytokines and Endothelial Death – Christine Cunningham, BS (1:10:54)
-
Therapeutic Potential of the Nuclear Receptor Modulator SR9011 for Treatment of Pulmonary Hypertension – Roxane Paulin, PhD (1:24:30)
-
Intratracheal Gene Delivery of SIN3A Inhibits Pulmonary Arterial Hypertension and Restores BMPR2 Expression – Malik Bisserier, PhD (1:36:21)
-
Role of Checkpoint Kinases in Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis Wen Wu, PhD (1:44:50)
